Analyst Reco. H. Lundbeck A/S

Equities

HLUN B

DK0061804770

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 17/02/2026 pm IST			5-day change	1st Jan Change
40.12 ^DKK	-0.20%		+1.78%	-7.04%

17/02	Deutsche Bank Lowers Price Target for Lundbeck to 40 Danish Kroner (44), Maintains Hold Recommendation	FW
16/02	DNB Carnegie Raises Price Target for Lundbeck to 53 Danish Kroner (51), Reiterates Buy	FW

Analyst Reco.

17/02	Deutsche Bank Lowers Price Target for Lundbeck to 40 Danish Kroner (44), Maintains Hold Recommendation	FW
16/02	DNB Carnegie Raises Price Target for Lundbeck to 53 Danish Kroner (51), Reiterates Buy	FW
12/02	Barclays Lowers Price Target for Lundbeck to 45 Danish Kroner (from 50), Maintains Equal Weight - BN	FW
06/02	H Lundbeck: Weak 2026 outlook a turn-off for investors
05/02	Danske Bank Lowers Price Target for Lundbeck to 48 Danish Kroner (52), Reiterates Buy - BN	FW
05/02	UBS Lowers Price Target for Lundbeck to 42 Danish Kroner (46), Reiterates Neutral Rating	FW
05/02	SEB Lowers Price Target for Lundbeck to 43 Danish Kroner (from 50), Maintains Hold Recommendation	FW
29/01	DNB Carnegie Lowers Price Target for Lundbeck to 51 Danish Kroner (53), Reiterates Buy	FW
20/01	Danske Bank Lowers Price Target for Lundbeck to 52 Danish Kroner (55), Reiterates Buy - BN	FW
07/01	Barclays Lowers Price Target for Lundbeck to 50 Danish Kroner (from 53), Maintains Equal Weight - BN	FW
03/12	BNP Paribas Exane Raises Price Target for Lundbeck to 45 Danish Kroner, Reiterates Neutral Rating - BN	FW
20/11	UBS Raises Lundbeck Target Price to 46 Danish Kroner, Maintains Neutral Rating	FW
18/11	Barclays Raises Price Target for Lundbeck to 53 Danish Kroner, Reiterates Equal Weight	FW
14/11	H Lundbeck lifts guidance again as migraine and depression drugs drive growth
13/11	Kepler Cheuvreux Raises Target Price for Lundbeck to 65 Danish Kroner, Reiterates Buy	FW
13/11	SEB Raises Price Target for Lundbeck to 50 Danish Kroner, Reiterates Hold	FW
12/11	Nordea Raises Target Price for Lundbeck to 72 Danish Kroner (71), Reiterates Buy	FW
11/11	Jefferies Downgrades Lundbeck on Patent Concerns	FW
11/11	Jefferies Downgrades Lundbeck to Underperform, Lowers Target Price to 39 Danish Kroner	FW
10/11	Lundbeck Expected to Report DKK 1,844 Million in Adjusted EBITDA - Consensus	FW
28/25/28	SEB Lowers Lundbeck to Hold - Stock Price Reflects Fundamental Value	FW
28/25/28	SEB Downgrades Lundbeck to Hold (Buy), Sets Target Price at 48 Danish Kroner - BN	FW
22/25/22	BNP Paribas Exane Raises Price Target for Lundbeck to 42 Danish Kroner, Reiterates Neutral Rating	FW
13/25/13	H. Lundbeck's Investigational Drug Bexicaserin Wins Breakthrough Therapy Designation in China	MT
04/25/04	Handelsbanken Upgrades Lundbeck to Buy, Raises Target Price to 60 Danish Kroner	FW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

H Lundbeck: Weak 2026 outlook a turn-off for investors

February 06, 2026 at 09:35 pm IST

H. Lundbeck A/S : Lundbeck: possible rebound given outlook

November 20, 2024 at 03:08 pm IST